Most Active Stock Options October 19, 2009
As of today the top ten most active option contracts traded were:
- Financial Select Sector SPDR (NYSE:XLF) November 15 Put Options
- Financial Select Sector SPDR November 16 Call Options
- Pfizer (NYSE:PFE) December 19 Call Options
- PowerShares QQQ (NASDAQ:QQQQ) November 42 Put Options
- Citigroup (NYSE:C) November 5 Call Options
- Pfizer December 18 Call Options
- S&P 500 SPDR (NYSE:SPY) November 107 Put Options
- S&P 500 SPDR November 110 Call Options
- S&P 500 SPDR November 108 Put Options
- Pfizer January 20 Call Options
There
seems to be a lot of speculation rushing into Pfizer before they report
earnings tomorrow. According to today's option activity it looks like
some bullish activity in Pfizer is expected. If you checked out today's
option activity in Apple (
AAPL) you would have noticed way more calls
were traded than puts and the options traders had it right, with a
total, what I call, WOWZER quarter from Apple. The gross margins seemed
to be a little lighter than expected, but everything else was great! If
you read my blog post from this morning, you may have been able to
check out my Apple earnings strategy. If not check it out below. I am
very happy I opened this position, and think Apple has a shot at
trading higher than the after-hours high (roughly 205 a share) with the
help of other good earnings reports tomorrow morning. I also sold some
21 strike put options on Texas Instruments (
TXN) which I plan on
closing tomorrow on implied volatility collapse, and sold 52.50 and 55
strike Caterpillar (
CAT) puts which I will also look to close on
implied volatility collapse after CAT reports earnings.
The above story is the opinion of the author only and it does not reflect
iStockAnalyst opinion. Further, the author is not personally advising you
regarding the suitability of the story for your investment needs. In no event
iStockAnalyst will be liable for any loss or damage including without
limitation, indirect or consequential loss or damage, or any loss or damage
whatsoever arising from or arising out of, or in connection with the use of this
information. Please consult your investment advisor before making any investment
decision.